{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:00:28Z","timestamp":1790528428402,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health","award":["AR51190 to WG; R01 AR50785"],"award-info":[{"award-number":["AR51190 to WG; R01 AR50785"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171679"],"award-info":[{"award-number":["81171679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.intimp.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T15:47:04Z","timestamp":1331912824000},"page":"28-36","source":"Crossref","is-referenced-by-count":15,"title":["Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts- from the point of view of mouse genomics"],"prefix":"10.1016","volume":"13","author":[{"given":"Yanhong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Postlethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2012.02.014_bb0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/344633a0","article-title":"Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein","volume":"344","author":"Carter","year":"1990","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2012.02.014_bb0010","doi-asserted-by":"crossref","first-page":"i103","DOI":"10.1136\/ard.59.suppl_1.i103","article-title":"Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis","volume":"59","author":"Schiff","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2012.02.014_bb0015","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/art.1780370917","article-title":"Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus","volume":"37","author":"Blakemore","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2012.02.014_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0016-5085(94)90696-3","article-title":"Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist","volume":"106","author":"Mansfield","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2012.02.014_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/WNL.52.3.595","article-title":"Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene","volume":"103","author":"Tarlow","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.intimp.2012.02.014_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.52.3.595","article-title":"Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS","volume":"52","author":"Schrijver","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2012.02.014_bb0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02185776","article-title":"Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus","volume":"97","author":"Blakemore","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.intimp.2012.02.014_bb0045","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1210\/jc.2005-2786","article-title":"Interleukin-1 system gene polymorphisms are associated with fat mass in young men","volume":"91","author":"Strandberg","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.intimp.2012.02.014_bb0050","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2012.02.014_bb0055","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2012.02.014_bb0060","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1902\/jop.2010.100073","article-title":"Association of interleukin-1 receptor antagonist gene polymorphisms with generalized aggressive periodontitis in an Iranian population","volume":"81","author":"Baradaran-Rahimi","year":"2010","journal-title":"J Periodontol"},{"key":"10.1016\/j.intimp.2012.02.014_bb0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.humimm.2011.05.009","article-title":"Single nucleotide polymorphisms in interleukin-1gene cluster and subgingival colonization with Aggregatibacter actinomycetemcomitans in patients with aggressive periodontitis","volume":"72","author":"Schulz","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.intimp.2012.02.014_bb0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.2009.108068","article-title":"IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease","volume":"69","author":"Naumann","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2012.02.014_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0066-782X2008001700002","article-title":"Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease","volume":"91","author":"Arman","year":"2008","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.intimp.2012.02.014_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2010.02.1031","article-title":"Convergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian population","volume":"120","author":"Xu","year":"2010","journal-title":"Schizophr Res"},{"issue":"6776","key":"10.1016\/j.intimp.2012.02.014_rf0165","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"issue":"6842","key":"10.1016\/j.intimp.2012.02.014_rf0170","first-page":"99","volume":"412","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2012.02.014_bb0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1158\/1055-9965.EPI-09-0917","article-title":"Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis","volume":"19","author":"Peleteiro","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.intimp.2012.02.014_bb0095","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.014_bb0100","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MOP.0b013e32834cba24","article-title":"Update on the pathogenesis and treatment of systemic idiopathic arthritis","volume":"23","author":"Sikora","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.intimp.2012.02.014_bb0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/RHU.0b013e318205092d","article-title":"Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2012.02.014_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/RHU.0b013e318205092d","article-title":"Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids","volume":"17","author":"Bruck","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.014_bb0115","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2177\/jsci.34.361","article-title":"Progress in classification and treatment for TNF receptor-associated periodic syndrome","volume":"34","author":"Tsukamoto","year":"2011","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"10.1016\/j.intimp.2012.02.014_bb0120","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/j.1756-185X.2011.01629.x","article-title":"Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout","volume":"14","author":"Tran","year":"2011","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.014_bb0125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jbspin.2011.03.021","article-title":"Anakinra: an effective treatment in the Schnitzler syndrome","volume":"78","author":"Vandenhende","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2012.02.014_bb0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12348-010-0018-2","article-title":"Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra","volume":"1","author":"Terrada","year":"2011","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.intimp.2012.02.014_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000326112","article-title":"Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret\u00ae) in a case of refractory Sweet's syndrome","volume":"222","author":"Kluger","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.intimp.2012.02.014_bb0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.30149","article-title":"Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle\u2013Wells syndrome","volume":"63","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2012.02.014_bb0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3928\/01477447-20101021-09","article-title":"Clinical benefits of intra-articular anakinra for arthrofibrosis","volume":"33","author":"Brown","year":"2010","journal-title":"Orthopedics"},{"key":"10.1016\/j.intimp.2012.02.014_bb0150","article-title":"Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure","volume":"29","author":"Stankovic Stojanovic","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.intimp.2012.02.014_bb0155","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1158\/1535-7163.MCT-10-0156","article-title":"Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra)","volume":"9","author":"El-Osta","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.intimp.2012.02.014_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0031-1275398","article-title":"Clinical benefits of intra-articular anakinra for persistent knee effusion","volume":"24","author":"Brown","year":"2011","journal-title":"J Knee Surg"},{"key":"10.1016\/j.intimp.2012.02.014_bb0165","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00296-010-1787-5","article-title":"Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID\/CINCA)","volume":"31","author":"Rigante","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.intimp.2012.02.014_bb0170","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.2147\/IJGM.S23920","article-title":"Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene","volume":"17","author":"Lin","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.intimp.2012.02.014_bb0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/IJGM.S23920","article-title":"Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports","volume":"4","author":"Mahamid","year":"2011","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.intimp.2012.02.014_bb0180","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/jc.2010-2992","article-title":"Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study","volume":"96","author":"van Asseldonk","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.intimp.2012.02.014_bb0185","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1476-5381.2009.00331.x","article-title":"Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy","volume":"157","author":"Luheshi","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.014_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nn0504-485","article-title":"WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior","volume":"7","author":"Chesler","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.intimp.2012.02.014_bb0195","first-page":"5","article-title":"A new set of BXD recombinant inbred lines from advanced intercross populations in mice","volume":"29","author":"Peirce","year":"2004","journal-title":"BMC Genet"},{"key":"10.1016\/j.intimp.2012.02.014_bb0200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/genetics\/176.2.729","article-title":"Haldane, Bailey, Taylor and recombinant-inbred lines","volume":"176","author":"Crow","year":"2007","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.014_bb0205","doi-asserted-by":"crossref","first-page":"e15860","DOI":"10.1371\/journal.pone.0015860","article-title":"Temporal and tissue specific regulation of RP-associated splicing factor genes PRPF3, PRPF31 and PRPC8\u2014implications in the pathogenesis of RP","volume":"6","author":"Cao","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.014_bb0210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/hmg\/ddq473","article-title":"Systemic splicing factor deficiency causes tissue-specific defects: a zebrafish model for retinitis pigmentosa","volume":"20","author":"Linder","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.014_bb0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1242\/dev.051409","article-title":"Integration of RNA processing and expression level control modulates the function of the Drosophila Hox gene Ultrabithorax during adult development","volume":"138","author":"de Navas","year":"2011","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.014_bb0220","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cyto.2006.02.003","article-title":"Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway","volume":"33","author":"Evans","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2012.02.014_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","article-title":"Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice","volume":"191","author":"Horai","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2012.02.014_bb0230","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/art.21481","article-title":"Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background","volume":"52","author":"Zhou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2012.02.014_bb0235","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/ATVBAHA.109.201749","article-title":"Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB\/c mice","volume":"30","author":"Isoda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.intimp.2012.02.014_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2011.11.028","article-title":"Deficiency of interleukin-1 receptor antagonist promotes spontaneous femoral artery aneurysm formation in mice","author":"Isoda","year":"2012","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.intimp.2012.02.014_bb0245","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbi.2008.03.005","article-title":"Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice","volume":"22","author":"Wolf","year":"2008","journal-title":"Brain Behav Immun"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:38:51Z","timestamp":1641256731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1567576912000665"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.02.014","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}